Boston Non Current Liabilities Total from 2010 to 2025
| BSX Stock | USD 99.36 1.44 1.43% |
Non Current Liabilities Total | First Reported 1991-12-31 | Previous Quarter 11.2 B | Current Value 11 B | Quarterly Volatility 4.8 B |
Check Boston Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boston Scientific's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 B, Interest Expense of 198.1 M or Selling General Administrative of 6.3 B, as well as many indicators such as Price To Sales Ratio of 4.7, Dividend Yield of 4.0E-4 or PTB Ratio of 5.9. Boston financial statements analysis is a perfect complement when working with Boston Scientific Valuation or Volatility modules.
Boston | Non Current Liabilities Total |
Latest Boston Scientific's Non Current Liabilities Total Growth Pattern
Below is the plot of the Non Current Liabilities Total of Boston Scientific Corp over the last few years. It is Boston Scientific's Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Boston Scientific's overall financial position and show how it may be relating to other accounts over time.
| Non Current Liabilities Total | 10 Years Trend |
|
Non Current Liabilities Total |
| Timeline |
Boston Non Current Liabilities Total Regression Statistics
| Arithmetic Mean | 8,585,824,412 | |
| Geometric Mean | 6,140,956,966 | |
| Coefficient Of Variation | 34.62 | |
| Mean Deviation | 2,120,778,640 | |
| Median | 8,512,000,000 | |
| Standard Deviation | 2,972,035,559 | |
| Sample Variance | 8832995.4T | |
| Range | 11.8B | |
| R-Value | 0.54 | |
| Mean Square Error | 6673279T | |
| R-Squared | 0.29 | |
| Significance | 0.03 | |
| Slope | 338,982,145 | |
| Total Sum of Squares | 132494930.5T |
Boston Non Current Liabilities Total History
About Boston Scientific Financial Statements
Boston Scientific investors use historical fundamental indicators, such as Boston Scientific's Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Boston Scientific. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Current Liabilities Total | 11 B | 6.4 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.